Hema Now: A Conversation with the ASH President

In this episode of Hema Now, Robert Negrin, President of the American Society of Hematology (ASH), reflects on his distinguished career in stem cell transplantation and cellular therapy, and shares his vision for the future of the field. From shaping global haematology priorities to advancing innovative treatments such as CAR-T cell therapy, he explores both the remarkable progress and the ongoing challenges facing clinicians and researchers today. The conversation also highlights the importance of translational research, mentorship, and collaboration in driving meaningful improvements in patient care, while looking ahead to the technologies and breakthroughs that could redefine haematology in the years to come. Timestamps:   00:00 - Introduction  01:20 - Presidency priorities, mission advancement   05:45 - Evolving global haematology needs   08:17 - Career inspiration, key developments   16:13 - Cellular therapy opportunities, challenges   19:47 - Translational research importance   22:22 - Future of stem transplantation   26:08 - Mentorship principles, trainee guidance   29:45 - Emerging technologies impact   30:40 - Three wishes, haematology future